Although primarily used as a biomarker for neuroendocrine tumors, elevated CgA levels have been observed in metabolic and inflammatory disorders such as diabetes, thyroid disease, and cardiovascular conditions (5–8), suggesting its broader role in metabolic regulation and immune signaling. Here, CGA is linked to neuroendocrine neoplasm.